Earnings Call · Q4 FY2023·2024-02-22

Q4 23EPS +26.40%·Rev n/aQ3 23EPS +8.06%·Rev n/aQ2 23EPS +3.28%·Rev n/aQ1 23EPS -12.58%·Rev n/a⚠ consensus missing

COLLEGIUM PHARMACEUTICAL, INC COLL

Christopher James — Unknown (likely IR or Communications)

Joseph Ciaffoni — Chief Executive Officer

Colleen Tupper — Chief Financial Officer

Scott Dreyer — Chief Commercial Officer

+10.8%1d on move date+10.7% vs SPY3d+12.1%5d+11.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more COLL calls or request research access.

More COLL calls Browse calls Request research access